John G - Search Results

1

Slowly inactivating component of sodium current in ventricular myocytes is decreased by diabetes and partially inhibited by known Na(+)-H(+)Exchange blockers.

Chattou S, Coulombe A, Diacono J, Le Grand B, John G, Feuvray D. Chattou S, et al. Among authors: john g. J Mol Cell Cardiol. 2000 Jul;32(7):1181-92. doi: 10.1006/jmcc.2000.1151. J Mol Cell Cardiol. 2000. PMID: 10860762

2

Anti-ischemic compound KC 12291 prevents diastolic contracture in isolated atria by blockade of voltage-gated sodium channels.

Tamareille S, Le Grand B, John GW, Feuvray D, Coulombe A. Tamareille S, et al. J Cardiovasc Pharmacol. 2002 Sep;40(3):346-55. doi: 10.1097/00005344-200209000-00003. J Cardiovasc Pharmacol. 2002. PMID: 12198320

3

Ketanserin inhibits the transient outward current in rabbit ventricular myocytes.

Le Grand B, Marty A, Colpaert FC, John GW. Le Grand B, et al. Among authors: john gw. J Cardiovasc Pharmacol. 1995 Feb;25(2):341-4. doi: 10.1097/00005344-199502000-00022. J Cardiovasc Pharmacol. 1995. PMID: 7752662

4

HOE 694 affords protection versus veratrine contractures in rat atria by Na+ channel blockade.

Le Grand B, Marty A, Talmant JM, John GW. Le Grand B, et al. Among authors: john gw. Fundam Clin Pharmacol. 1996;10(5):467-73. doi: 10.1111/j.1472-8206.1996.tb00602.x. Fundam Clin Pharmacol. 1996. PMID: 8902550

5

Late sodium current inhibition in human isolated cardiomyocytes by R 56865.

Le Grand B, Coulombe A, John GW. Le Grand B, et al. Among authors: john gw. J Cardiovasc Pharmacol. 1998 May;31(5):800-4. doi: 10.1097/00005344-199805000-00021. J Cardiovasc Pharmacol. 1998. PMID: 9593082

6

Thrombin facilitation of voltage-gated sodium channel activation in human cardiomyocytes: implications for ischemic sodium loading.

Pinet C, Le Grand B, John GW, Coulombe A. Pinet C, et al. Circulation. 2002 Oct 15;106(16):2098-103. doi: 10.1161/01.cir.0000034510.64828.96. Circulation. 2002. PMID: 12379580

7

Alleviation of contractile dysfunction in ischemic hearts by slowly inactivating Na+ current blockers.

Le Grand B, Vie B, Talmant JM, Coraboeuf E, John GW. Le Grand B, et al. Among authors: john gw. Am J Physiol. 1995 Aug;269(2 Pt 2):H533-40. doi: 10.1152/ajpheart.1995.269.2.H533. Am J Physiol. 1995. PMID: 7653617

8

Study of the interaction of lubeluzole with cardiac sodium channels.

Le Grand B, Talmant JM, Rieu JP, Patoiseau JF, John GW. Le Grand B, et al. J Cardiovasc Pharmacol. 2003 Nov;42(5):581-7. doi: 10.1097/00005344-200311000-00001. J Cardiovasc Pharmacol. 2003. PMID: 14576504

9

KC 12291: an atypical sodium channel blocker with myocardial antiischemic properties.

John GW, Létienne R, Le Grand B, Pignier C, Vacher B, Patoiseau JF, Colpaert FC, Coulombe A. John GW, et al. Cardiovasc Drug Rev. 2004 Spring;22(1):17-26. doi: 10.1111/j.1527-3466.2004.tb00129.x. Cardiovasc Drug Rev. 2004. PMID: 14978516 Review.

10

Veratrine-induced tetanic contracture of the rat isolated left atrium. Evidence for novel direct protective effects of prazosin and WB4101.

Le Grand B, Marty A, Vieu S, Talmant JM, John GW. Le Grand B, et al. Among authors: john gw. Naunyn Schmiedebergs Arch Pharmacol. 1993 Aug;348(2):184-90. doi: 10.1007/BF00164797. Naunyn Schmiedebergs Arch Pharmacol. 1993. PMID: 7901775

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

816 results

Search Page

Filters